+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

France Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 78 Pages
  • January 2022
  • Region: France
  • Mordor Intelligence
  • ID: 4987300

The rise in the number of chronic obstructive pulmonary disease (COPD), TB, asthma, and pneumonia cases remains the major drivers of the industry. Chronic respiratory diseases are chronic diseases that affect the airways and other parts of the lungs. Respiratory symptoms are among the major causes of consultation with doctors and physicians in primary health care centers. Some of the major preventable chronic respiratory disorders are asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, sleep apnea, and tuberculosis (principally, multi-drug resistant tuberculosis). Asthma is one of the key indicators of this market, which affects children, adults, and elderly people. According to a European Respiratory Journal , the prevalence of asthma in France is estimated to be around 6.4% in 2018. Thus, with these factors, the adoption rate and demand for respiratory diseases are expected to grow substantially, over the forecast period.

Key Market Trends

Spirometers Segment is Expected to Show Better Growth in the Forecast Years

Based on diagnostic and monitoring devices segment, it is categorized into spirometers, sleep test devices, peak flow meters, pulse oximeters, capnographs and others. The main factor attributing to the growth of spirometers segment is the increasing burden of respiratory disorders, such as asthma, bronchitis, and COPD across the country. The wide application of spirometers makes it easier for the patients to use this device and is thus, increasingly adopted in hospitals and home care settings. Furthermore, the significant advancements in the field of spirometry include the development of small portable spirometers and the increasing accuracy and acceptability, which is expected to fuel the market growth over the forecast period.

Competitive Landscape

The global players into the France respiratory devices market are Dragerwerk AG, Drive Devilbiss International, Fisher & Paykel Healthcare Limited, GE Healthcare, GlaxoSmithKline PLC, Invacare Corporation, Koninklijke Philips N.V, Medtronic PLC and ResMed Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Respiratory Disorders
4.2.2 Technological Advancements
4.2.3 Large Patient Population
4.3 Market Restraints
4.3.1 High Cost of Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type
5.1.1 By Diagnostic and Monitoring Devices Spirometers Sleep Test Devices Peak Flow Meters Pulse Oximeters Capnographs Other Diagnostic and Monitoring Devices
5.1.2 By Therapeutic Devices CPAP Devices BiPAP Devices Humidifiers Nebulizers Oxygen Concentrators Ventilators Inhalers Other Therapeutic Devices
5.1.3 By Disposables Masks Breathing Circuits Other Disposables
6.1 Company Profiles
6.1.1 Dragerwerk AG
6.1.2 Drive Devilbiss International
6.1.3 Fisher & Paykel Healthcare Limited
6.1.4 GE Healthcare
6.1.5 GlaxoSmithKline PLC
6.1.6 Invacare Corporation
6.1.7 Koninklijke Philips N.V
6.1.8 Medtronic PLC
6.1.9 ResMed Inc.